2014
DOI: 10.1097/igc.0000000000000149
|View full text |Cite
|
Sign up to set email alerts
|

Patient Preferences for Side Effects Associated With Cervical Cancer Treatment

Abstract: Objectives To assess patient preferences regarding side effects associated with cervical cancer treatment. Methods/Materials The visual analog scale (VAS) and modified standard gamble (SG) were used to elicit preferences of women with no evidence of disease following primary treatment for cervical cancer. Higher scores on VAS and SG indicated more favorable ratings for a given health state (HS). HS included: vaginal shortening (VAG), diarrhea, dietary changes (DIET), menopause, moderate nausea/vomiting (NV),… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 27 publications
0
13
0
Order By: Relevance
“…40 Quality of life assessment is defined by individual factors which are changing with time. 41 Physicians should discuss possible disease-related and treatment-related problems before and after treatment.…”
Section: Discussionmentioning
confidence: 99%
“…40 Quality of life assessment is defined by individual factors which are changing with time. 41 Physicians should discuss possible disease-related and treatment-related problems before and after treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Visual analog scale.-Using a "feeling thermometer" (19) (Fig. 1) adapted from prior studies (20), women were asked to read each health state description and rank each health state ranging from 0 (least preferred) to 100 (most preferred). Preference scores were calculated by dividing the number corresponding to health state rankings by 100 (i.e., 75/100 = .75).…”
Section: Dmentioning
confidence: 99%
“…AUROC curve was also used for evaluation of different techniques [18,27] in biomedical data mining. There are 50% of cervical cancer identification in females age (35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54) and around 20% diagnosed more than 65 years old as well as around 15% of between the age of (20 -30). Median age for diagnosis in cervical cancer is 48 years.…”
Section: Resultsmentioning
confidence: 99%
“…In any case, several young females end up infected with different sorts of human papilloma infection (HPV), which can expand their danger of getting cervical cancer in future. Young females with early abnormal changes who don't have regular checkup are at high risk of cervical cancer when they reach at the age of 40 [43][44][45]. The main risk factor for cervical cancer growth is HPV.…”
Section: Resultsmentioning
confidence: 99%